{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:58:03Z","timestamp":1777507083394,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.anai.2024.05.010","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T01:59:54Z","timestamp":1716256794000},"page":"168-176.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fractional exhaled nitric oxide, a potential biomarker for evaluating glucocorticoids treatment and prognosis in allergic bronchopulmonary aspergillosis"],"prefix":"10.1016","volume":"133","author":[{"given":"Li-sha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-yi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-8973","authenticated-orcid":false,"given":"Jin-fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anai.2024.05.010_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/ijmr.IJMR_1187_19","article-title":"Allergic bronchopulmonary aspergillosis","volume":"151","author":"Agarwal","year":"2020","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0002","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1016\/j.anai.2024.05.010_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/jof2020017","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Tracy","year":"2016","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"10.1016\/j.anai.2024.05.010_bib0004","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.anai.2024.05.010_bib0005","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.rmed.2012.03.001","article-title":"Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.anai.2024.05.010_bib0006","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.anai.2024.05.010_bib0007","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2024.05.010_bib0008","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2024.05.010_bib0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2019.07.010","article-title":"Scottish consensus statement on the role of FeNO in adult asthma","volume":"155","author":"Kuo","year":"2019","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0010","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.anai.2024.05.010_bib0011","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/17476348.2016.1249853","article-title":"Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis","volume":"10","author":"Agarwal","year":"2016","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.01.062","article-title":"Prevention and management of glucocorticoid-induced side effects: a comprehensive review: a review of glucocorticoid pharmacology and bone health","volume":"76","author":"Caplan","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0014","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jaip.2020.08.043","article-title":"Which are the optimal criteria for the diagnosis of allergic bronchopulmonary aspergillosis? A latent class analysis","volume":"9","author":"Saxena","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.05.010_bib0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.anai.2024.05.010_bib0016","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00386-2024","article-title":"Th2-skewed peripheral T-helper cells drive B-cells in allergic bronchopulmonary aspergillosis","volume":"63","author":"Luo","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0018","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1111\/apa.12930","article-title":"The diagnostic criteria for allergic bronchopulmonary aspergillosis in children with poorly controlled asthma need to be re-evaluated","volume":"104","author":"Singh","year":"2015","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12423","article-title":"Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis","volume":"59","author":"Agarwal","year":"2016","journal-title":"Mycoses"},{"issue":"2","key":"10.1016\/j.anai.2024.05.010_bib0020","article-title":"Chemokines in asthma: cooperative interaction between chemokines and IL-13","volume":"111","author":"Zimmermann","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0021","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/aap.2015.36.3805","article-title":"FeNO as biomarker for asthma phenotyping and management","volume":"36","author":"Ricciardolo","year":"2015","journal-title":"Allergy Asthma Proc"},{"issue":"suppl 2","key":"10.1016\/j.anai.2024.05.010_bib0022","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.29262\/ram.v67i0.760","article-title":"[Mexican consensus on fractional exhaled nitric oxide (FeNO) in asthma 2020]","volume":"67","author":"Larenas-Linnemann","year":"2020","journal-title":"Rev Alerg Mex"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0023","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0042-1743290","article-title":"FeNO in asthma","volume":"43","author":"Loewenthal","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2024.05.010_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0091-6749(88)90995-5","article-title":"Analysis of bronchoalveolar lavage in allergic bronchopulmonary aspergillosis: divergent responses of antigen-specific antibodies and total IgE","volume":"82","author":"Greenberger","year":"1988","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/myc.12541","article-title":"Role of Aspergillus fumigatus-specific IgG in diagnosis and monitoring treatment response in allergic bronchopulmonary aspergillosis","volume":"60","author":"Agarwal","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.anai.2024.05.010_bib0026","article-title":"Clinical and immunological characteristics of Aspergillus fumigatus-sensitized asthma and allergic bronchopulmonary aspergillosis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.05.010_bib0027","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0091-6749(84)90089-7","article-title":"Serum IgE as an important aid in management of allergic bronchopulmonary aspergillosis","volume":"74","author":"Ricketti","year":"1984","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0028","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2024.05.010_bib0029","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.anai.2024.05.010_bib0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India","volume":"130","author":"Agarwal","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.anai.2024.05.010_bib0031","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ppul.20088","article-title":"Dornase alpha and exhaled NO in cystic fibrosis","volume":"38","author":"Grasemann","year":"2004","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.anai.2024.05.010_bib0032","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1164\/ajrccm.162.6.2003106","article-title":"Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene","volume":"162","author":"Grasemann","year":"2000","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624003053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T16:54:21Z","timestamp":1722617661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1081120624003053"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.010","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractional exhaled nitric oxide, a potential biomarker for evaluating glucocorticoids treatment and prognosis in allergic bronchopulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}